Association of plasma proteomics with incident coronary heart disease in individuals with and without type 2 diabetes: results from the population-based KORA study
Hong Luo(Jiangxi Provincial Cancer Hospital), Barbara Thorand(Helmholtz Zentrum München), Agnese Petrera(Helmholtz Zentrum München), Stefanie M. Hauck(Center for Environmental Health), Wolfgang Köenig(German Centre for Cardiovascular Research), Annika Hoyer(Bielefeld University), Christian Herder(Düsseldorf University Hospital), Marie‐Theres Huemer(Helmholtz Zentrum München), Annette Peters(Zimmer Biomet (Netherlands)), Wolfgang Rathmann(Deutsches Diabetes-Zentrum e.V.)
Cited by 16
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k